Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains. - Wikidata - awgldk - TriplyDB

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

http://www.wikidata.org/entity/Q34365810

about

Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany An Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses.Relationship between within-host fitness and virulence in the vesicular stomatitis virus: correlation with partial decoupling Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.Experimental evolution of an RNA virus in cells with innate immunity defects.

P2860

Q33766951-736D4EC5-7BA9-4C2E-941F-BF9AF3FD7786 Q36316673-09B82F69-E311-45F0-88BC-20221F73BEA8 Q36363838-0E74DBF7-CAD2-42BD-8799-0AEB90EACBA4 Q40269934-B4F97380-AD08-404B-821B-03BDA874E2F2 Q40520906-C79C53A3-E426-4096-8C86-AA2BEA02E297

P2860

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

http://www.wikidata.org/entity/Q34365810

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

@ast

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

@en

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

@nl

type

label

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

@ast

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

@en

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

@nl

prefLabel

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

@ast

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

@en

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

@nl

P1433

Q34365810-8D42F4BF-FEF0-446B-945F-CAF62F8E4D23

P1476

Q34365810-FFBACE99-C2E3-4D85-B767-6B9443CCB1F7

P2093

Q34365810-36107B1B-0F48-4BB2-9E02-580CCCF45CB1

Q34365810-F47902E8-3E30-4DE6-91CA-ECF0C47FD956

P2860

Q34365810-01347D59-3C94-4A13-A95E-767669357A42

Q34365810-0905A450-E4A8-4C4C-BB3A-E58A609D2CB1

Q34365810-0CA639FB-2234-4858-95DE-DC5ADA7FD832

Q34365810-11F5864B-F374-46B2-B0EF-0459D63A8BC6

Q34365810-2015B90C-84F9-46FA-85AE-541376C7503F

Q34365810-233FF6C1-3CFE-46E1-A316-82FDE9A4422E

Q34365810-3342B666-79EB-4999-9D67-7B08084A7CEE

Q34365810-349F0C22-CA7D-4DB8-B49D-043753E45602

Q34365810-38501AF1-DCC5-49F6-9B0F-86667A1B29B8

Q34365810-3F2ECD2D-8F6F-45F5-8E97-5C17ADC9980C

P304

Q34365810-57D9AA03-2A0F-406B-A06E-F84A03083691

P31

Q34365810-C114C759-036B-4BCB-A854-9AF3092EDB7B

P356

Q34365810-0C07CB4D-2FF4-4D4F-A2EF-11AD233E0EC4

P407

Q34365810-5056D8E4-3056-4B8F-A1F1-C1412BE4B0F8

P433

Q34365810-144E9DC7-F54E-47B6-94BD-52C1EB293930

P478

Q34365810-4F61449A-A6AB-4F8A-9B57-1CC653210403

P577

Q34365810-037CC94E-640E-45AB-91EA-DA649B4861F5

P5875

Q34365810-A577A65C-6FEA-44F8-A6F1-EF2DBAAE71FB

P698

Q34365810-6D2C549E-6BDD-4B1B-895C-A710AC842F68

P921

Q34365810-E94BB747-3E21-43AA-8B75-8A65AF9BC571

P932

Q34365810-93942AAA-4A1A-4A0A-BF3A-1D2DC5D00C9A

P356

JVI.76.11.5339-5349.2002

P1433

Journal of Virology

P1476

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.

@en

P2093

Javier Martín

http://www.w3.org/2001/XMLSchema#string

Philip D Minor

http://www.w3.org/2001/XMLSchema#string

P2860

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome

Oral immunization against poliomyelitis

Interaction of the poliovirus receptor with poliovirus

Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus

Structural studies of poliovirus mutants that overcome receptor defects

Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions

Three-dimensional structure of poliovirus at 2.9 A resolution.

New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence.

Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient.

P304

5339-5349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.76.11.5339-5349.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11378382

http://www.w3.org/2001/XMLSchema#string

P698

11991962

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

P932

137059

http://www.w3.org/2001/XMLSchema#string